DrugPatentWatch Database Preview
Drugs in Development Information for Misonidazole
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
What is the drug development status for Misonidazole?
Misonidazole is an investigational drug.
There have been 13 clinical trials for Misonidazole.
The most recent clinical trial was a Phase 2 trial, which was initiated on June 1st 2012.
The most common disease conditions in clinical trials are Glioblastoma, Lung Neoplasms, and Carcinoma, Squamous Cell. The leading clinical trial sponsors are National Cancer Institute (NCI), Proacta, Incorporated, and University of Arkansas.
There are seven hundred and eighty-one US patents protecting this investigational drug and six international patents.
Summary for Misonidazole
| US Patents | 781 |
| International Patents | 6,379 |
| US Patent Applications | 1,223 |
| WIPO Patent Applications | 829 |
| Japanese Patent Applications | 4 |
| Clinical Trial Progress | Phase 2 (2012-06-01) |
| Vendors | 18 |
Recent Clinical Trials for Misonidazole
| Title | Sponsor | Phase |
|---|---|---|
| Feasibility of FMISO in Brain Tumors | National Cancer Institute (NCI) | Phase 2 |
| Feasibility of FMISO in Brain Tumors | OHSU Knight Cancer Institute | Phase 2 |
| Pilot Study of 18F-FMISO PET/CT and MRI Imaging to Explore Tissue Hypoxia and Arteriovenous Shunting in Subjects With Recurrent Glioblastoma Before and After Bevacizumab Treatment | Abramson Cancer Center of the University of Pennsylvania | Phase 1 |
Clinical Trial Summary for Misonidazole
Top disease conditions for Misonidazole
Top clinical trial sponsors for Misonidazole
US Patents for Misonidazole
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Misonidazole | Start Trial | 1H-pyrrolo[2,3-B] pyridine derivatives and their use as kinase inhibitors | Vernalis (R&D) Limited (Winnersh, GB) | Start Trial |
| Misonidazole | Start Trial | Anti-transglutaminase 2 antibodies | LifeArc (London, GB) | Start Trial |
| Misonidazole | Start Trial | Pharmaceutical compounds | Cascadian Therapeutics, Inc. (Seattle, WA) | Start Trial |
| Misonidazole | Start Trial | Small molecule HSP70 inhibitors | The Trustees of the University of Pennsylvania (Philadelphia, PA) The Wistar Institute of Anatomy and Biology (Philadelphia, PA) | Start Trial |
| Misonidazole | Start Trial | Macrocylic pyrimidine derivatives | Janssen Pharmaceutica NV (Beerse, BE) | Start Trial |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Misonidazole
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Misonidazole | Australia | 2013213954 | 2032-01-30 | Start Trial |
| Misonidazole | Brazil | 112014018795 | 2032-01-30 | Start Trial |
| Misonidazole | Canada | 2862940 | 2032-01-30 | Start Trial |
| Misonidazole | China | 104203948 | 2032-01-30 | Start Trial |
| Misonidazole | China | 106866658 | 2032-01-30 | Start Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
